ICAREWOUNDS moves into a new phase with pilot validation in three European countries

The ICAREWOUNDS consortium travelled to Riga for the THCS Midterm Meeting to present results to THCS Partnership and fellow projects funded under the same call

The ICAREWOUNDS European project consortium, represented by Gradiant (coordinator), University College Dublin (UCD) and the Instituto de Investigación Sanitaria Galicia Sur (IISGS), was in Riga on May 26–27 to present the project’s interim results at the Midterm Review Meeting organised by THCS. Furthermore, the consortium had the opportunity to attend presentations by the coordinators of other projects funded under the same call.

During the meeting, key progress was highlighted in the co-creation of the integrated care model for chronic wound management, as well as in the design of the AI-based digital platform aimed at improving clinical decision-making and care coordination.

Among the main milestones, partners reported the completion of a comprehensive review of current chronic wound management practices across Europe and the successful co-design of the integrated care model, involving stakeholders from the three pilot countries: Spain, Poland and Ireland.

Significant advances were also presented regarding the ICAREWOUNDS platform, which now integrates an AI-based clinical decision support system (CDSS) for chronic wounds treatment selection, and user interfaces tailored to healthcare professionals, patients, and caregivers.

Progress is also ongoing in the multicentre clinical study, with its first phase completed and further validation phases underway to assess the platform and care model in practice.

 

ICAREWOUNDS project has received funding from the European Commission, ISCIII, NCBR, HRB, AKA and MUR under the framework the co-fund partnership of Transforming Health and Care Systems, THCS, (GA N° 101095654 of the EU Horizon Europe Research and Innovation Programme)

Award nº AC23_2/00048 and nº AC23_2/00031 by Instituto de Salud Carlos III (ISCIII) through AES 2023 and within the THCS Partnership.

The content of this publication represents the views of the author only and is his/her sole responsibility. The European Commission does not accept any responsibility for use that may be made of the information it contains.

ICAREWOUNDS moves forward towards its clinical  study with the platform now completed 

The platform begins its study with healthcare professionals specialised in chronic wound management  As its first phase nears completion, the multicentre study will evaluate usability, trust and added value of a solution based on trustworthy AI and eHealth technologies  ICAREWOUNDS continues to advance towards its goal of transforming chronic wound care through digital technology and trustworthy Artificial Intelligence models.

READ MORE →

Subscribe to our newsletter

Subscribe to our newsletter and be the first to hear about our updates.
Don’t miss out, join our community today!